About Bryan D. Hayes, PharmD, FAACT, FASHP

Chief Science Officer, ALiEM
Creator and Lead Editor, CAPSULES series, ALiEMU
Clinical Pharmacist, EM and Toxicology, MGH
Assistant Professor of EM, Harvard Medical School
12 06, 2017

EM Pharmacotherapy Guidelines and Position Statements: Resource for ED Rotations

2017-06-26T19:41:54+00:00

EM Pharmacotherapy GuidelinesSeveral years ago I created a resource for my ED rotation that I share with pharmacy students, pharmacy residents, and EM physician residents. It contains most of the guidelines and position statements on EM drug therapy that I utilize most often and is updated as new iterations are published. We’d like to share this tool with you to be used/modified to meet your rotation needs.
(more…)

8 01, 2017

Top 10 ALiEM Clinical Posts of 2016

2017-01-18T20:24:52+00:00

top 10 ALiEM clinical postsSeasons greetings from the ALiEM team. We have been publishing so many posts this year that you may have missed a few. Did you catch at least the top 10 most-read ALiEM clinical posts, which were published in 2016? These include some Tricks of the Track pearls and clinical tips in toxicology, orthopedics, and neurology. Check them out.
(more…)

5 01, 2017

Top 8 Must-Know EM Pharmacotherapy Articles of 2016

2017-03-05T14:18:39+00:00

Top 8 must-know EM pharmacotherapy articles of 2016For the third consecutive year, we provide a quick summary of some important Emergency Medicine pharmacotherapy articles from the last 12 months. We have tried to focus on articles you may have missed, but are potentially high-impact for improving clinical practice in the ED. Without further ado, we present the 8 must-know EM pharmacotherapy articles of 2016.

(more…)

26 10, 2016

Magnesium for Rapid Atrial Fibrillation Rate-Control in the ED

2017-03-05T14:18:45+00:00

magnesium-ivWe love magnesium in the Emergency Department. It’s been said that magnesium is second-line for everything (kind of like doxycycline). But what about rate/rhythm control in atrial fibrillation (AF)? The 2014 AHA/ACC/HRS guideline for the management of patients with AF doesn’t mention magnesium at all.1 Dr. Josh Farkas (@PulmCrit) wrote about magnesium infusions for atrial fibrillation and torsade last year. His post looked at its use for cardioversion, rhythm-control, and rate-control in critically-ill patients. Our post will focus specifically on the IV magnesium data for rate-control in ED-related settings.

(more…)

24 08, 2016

‘Treat and Release’ after Naloxone – What is the Risk of Death?

2016-11-22T05:25:30+00:00

NaloxoneOften in the prehospital setting, naloxone is administered by EMS (or possibly a bystander) to reverse respiratory and CNS depression from presumed opioid overdose. The patient then wakes up, and not uncommonly, refuses transport to the hospital. The question is: Is it safe to ‘treat and release?’ Or, rather, what is the risk of death associated with this practice. A hot-off-the-press article, just published in Prehospital Emergency Care, addresses this question.

(more…)